Patents
Patents for C07D 517 - Heterocyclic compounds containing in the condensed system at least one hetero ring having selenium, tellurium, or halogen atoms as ring hetero atoms (452)
10/2010
10/13/2010CN101103037B Novel condensed polycyclic aromatic compound and use thereof
09/2010
09/21/2010US7799927 optical recording media with said organic dye as recording layer; high density Disk-Recordable (HD DVD-R)
08/2010
08/31/2010US7786310 Small molecule transcriptional activation domains
07/2010
07/28/2010EP2210883A2 Heterocyclic fused selenophene monomers
07/14/2010EP2207218A1 Field effect transistor
06/2010
06/15/2010US7737272 Diazaphosphacycle transition metal complexes
05/2010
05/27/2010WO2010058833A1 Novel heterocyclic compound and use thereof
05/27/2010WO2010058692A1 Novel compound, process for producing the compound, organic semiconductor material, and organic semiconductor device
05/20/2010US20100123123 Organic thin-film transistors
05/06/2010WO2010050779A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
04/2010
04/22/2010US20100099561 Heterobicyclic alkylthio-bridged isoxazolines
04/15/2010WO2010042877A1 Improved amino lipids and methods for the delivery of nucleic acids
04/15/2010WO2009034571A8 Selenophenes and selenophene-based polymers, their preparation and uses thereof
04/15/2010CA2740000A1 Improved amino lipids and methods for the delivery of nucleic acids
03/2010
03/24/2010EP2164833A2 Quinazolinamide derivatives
02/2010
02/25/2010WO2009034571A4 Selenophenes and selenophene-based polymers, their preparation and uses thereof
01/2010
01/27/2010EP2147923A1 Method for producing aromatic compound
01/26/2010CA2558727C Chalcogen-containing fused polycyclic organic material and method for prroducing same
01/07/2010WO2009034571A3 Selenophenes and selenophene-based polymers, their preparation and uses thereof
12/2009
12/10/2009WO2009148564A1 Selenophene and selenazole carboxylic acid derivatives
12/10/2009CA2726755A1 Selenophene and selenazole carboxylic acid derivatives
11/2009
11/18/2009CN100560589C Imidazoselenazole compounds and their use for prevention and/or treatment of diseases relative to protein aging
10/2009
10/13/2009US7601859 Organometallic complexes
10/06/2009US7598389 Silylated carboxamides
09/2009
09/09/2009EP2098527A1 Novel fused-ring aromatic compound, process for producing the same, and use thereof
08/2009
08/25/2009US7579478 Process for the purification of substituted benzoxazole compounds
07/2009
07/08/2009EP2077590A1 Field-effect transistor
07/02/2009WO2009081460A1 Spirooxazine radical derivatives and reversible isomerization reaction
06/2009
06/23/2009CA2362728C Improved aqueous solubility pharmaceutical formulations
06/10/2009CN100497348C Selenaza aromatic heterocyclic compound with anti-tumor activty and its preparation process and application
05/2009
05/26/2009CA2225903C Aromatic diselenides and selenosulfides, their preparation and their uses, more particularly their therapeutical use
05/06/2009CN101423522A Diperylene-3,4,6,7:12,13,15,16-octocarboxylic tetraimides compounds and production method thereof
04/2009
04/23/2009WO2005069735A3 Therapeutic methods and pharmaceutical compositions for treating warts with tellurium compounds
04/09/2009WO2009010694A3 Dyeing method using a styryl- or imine-type disulfide/thiol compound and stimuli, composition and device for implementing same
04/08/2009EP2044082A1 Substituted benzodithiophenes and benzodiselenophenes
03/2009
03/26/2009WO2009038120A1 Field effect transistor
02/2009
02/24/2009US7495019 Benzoisoselenazole derivatives with anti-inflammation, antivirus and antithrombosis activity and their use
02/24/2009US7494721 Light-emitting device, condensed polycyclic compound used therein and method for producing same
01/2009
01/28/2009CN101353353A Heterocyclic fused selenophene monomers
01/22/2009WO2009010694A2 Dyeing method using a styryl- or imine-type disulfide/thiol compound and stimuli, composition and device for implementing same
01/14/2009EP2014665A2 Selenium containing electrically conductive polymers and method of making them
01/14/2009EP2014664A2 Heterocyclic fused selenophene monomers
12/2008
12/18/2008WO2008043072A3 Cd80 antagonists for treating neoplastic disorders
12/04/2008WO2008146597A1 Method for producing aromatic compound
09/2008
09/18/2008WO2008112249A1 Synergistic interaction of notch-1 inhibitors with glucocorticoids
08/2008
08/05/2008US7408058 Regioisomerically pure oxochlorins and methods of synthesis
07/2008
07/02/2008CN101210024A Synthesis of middle position-tetraaryldiphenanthrene diselenoporphyrin derivative and application thereof
06/2008
06/19/2008WO2008070908A1 Chemical compounds and processes
05/2008
05/02/2008WO2008050726A1 Novel fused-ring aromatic compound, process for producing the same, and use thereof
04/2008
04/24/2008WO2008047896A1 Field-effect transistor
04/01/2008US7351481 electrical stability, better charge transporting capability, a high glass transition temperature, and does not crystallize; high-efficiency, low-voltage, high-luminance, long-lifespan; durability; color purity
04/01/2008CA2298974C Thiazolobenzoheterocycles, preparation and medicines containing same
01/2008
01/31/2008WO2008011957A1 Substituted benzodithiophenes and benzodiselenophenes
01/09/2008CN101103037A Novel condensed polycyclic aromatic compound and use thereof
12/2007
12/06/2007US20070282099 Heterocyclic fused imidazolone, dioxolone, imidazolethione and dioxolethione monomers
12/05/2007CN101081852A Heterocyclic fused imidazolone, dioxolone, imidazolethione and dioxolethione monomers
11/2007
11/22/2007US20070270563 CyclicOrganosilicon Compounds and the Use Thereof
10/2007
10/24/2007EP1847544A1 Novel condensed polycyclic aromatic compound and use thereof
07/2007
07/18/2007CN100999527A Selenaza aromatic heterocyclic compound with anti-tumor activty and its preparation process and application
07/11/2007CN1997650A Chalcogen-containing fused-ring polycyclic organic material and process for producing the same
05/2007
05/24/2007US20070117973 Chalcogen-containing fused polycyclic organic material and method for producing same
01/2007
01/30/2007US7169775 Amino methyl imidazoles as C5a receptor modulators
01/23/2007CA2191747C (a)-annelated pyrrole derivatives and pharmaceutical use thereof
12/2006
12/12/2006US7148232 Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof
11/2006
11/22/2006EP1724272A1 Chalcogen-containing fused-ring polycyclic organic material and process for producing the same
10/2006
10/10/2006US7119208 drugs that bind to and increases oxygen affinity of hemoglobin, and preventing polymerization and formation fibrous precipitates hemoglobin, used for treatment of sickle-cell disease
07/2006
07/27/2006WO2006077888A1 Novel condensed polycyclic aromatic compound and use thereof
03/2006
03/09/2006US20060051612 Light-emitting device, condensed polycyclic compound used therein and method for producing same
02/2006
02/21/2006US7001588 Expanded porphyrin compositions for tumor inhibition
01/2006
01/10/2006US6984656 Core modified porphyrins
11/2005
11/02/2005CN1690061A Imidazoselenazole compounds and their use for prevention and/or treatment of diseases relative to protein aging
10/2005
10/26/2005EP1589089A1 Light-emitting device, condensed polycyclic compound used therein and method for producing same
10/26/2005EP1163234B1 Pharmaceutical formulations with improved aqueous solubility
09/2005
09/22/2005WO2005087780A1 Chalcogen-containing fused-ring polycyclic organic material and process for producing the same
09/22/2005US20050209199 Anti-sickling agents
08/2005
08/18/2005US20050182047 Treatment of demyelinating disorders
07/2005
07/13/2005CN1637000A Imidazole ring-containing compound and organic electroluminescence display device
06/2005
06/16/2005US20050130979 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline (NBQX) or the quinoxalinedione is 9-methyl-amino-6-nitro-hexahydro-benzo(F) quinoxalinedione (PNQX) for treating demyelinating disorders
04/2005
04/07/2005US20050074632 electrical stability, better charge transporting capability, a high glass transition temperature, and does not crystallize; high-efficiency, low-voltage, high-luminance, long-lifespan; durability; color purity
02/2005
02/03/2005US20050026943 Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof
12/2004
12/07/2004CA2154668C Condensed heterocyclic glutamic acid derivatives as antiproliferative agents
11/2004
11/09/2004US6815459 Seleno compounds containing nitrone moiety, their preparation and their therapeutic uses
10/2004
10/26/2004US6809203 Oxazolo, thiazolo and selenazolo [4,5-C]-quinolin-4-amines and analogs thereof
10/14/2004US20040204347 administering an effective amount of an inhibitor of the interaction of glutamate with the alpha -amino-3-hydroxy-5-methyl-4-isoxazole-propionate (AMPA) receptor complex to treat demyelinating disorders
08/2004
08/05/2004WO2004065520A1 Light-emitting device, condensed polycyclic compound used therein and method for producing same
07/2004
07/07/2004CN1156461C Improved aqueous solubility pharmaceutical formulations
06/2004
06/24/2004US20040122041 Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof
06/10/2004WO2004024091A3 Expanded porphyrin compositions for tumor inhibition
06/10/2004US20040110820 Expanded porphyrin compositions for tumor inhibition
04/2004
04/28/2004CN1147493C Oxazolo, thiazole and selenazolo [4,5-C]-quinolin-4-amines and analoges thereof and pharmaceutical composition containing them
03/2004
03/30/2004US6713468 Methods of using thiazolobenzoheterocycles
03/25/2004WO2004024091A2 Expanded porphyrin compositions for tumor inhibition
03/09/2004US6703402 Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof
03/02/2004US6699647 Tellurium chemical sensitizers added to the photothermographic emulsion, for example tellurium complexed with four imidazolidin-2-thione groups and two chlorine atoms
01/2004
01/14/2004EP1380587A2 Oxazolo, thiazolo and selenazolo (4,5-c)-quinoline-4-amines and analogs thereof
01/13/2004US6677334 Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof
11/2003
11/27/2003US20030220337 Use in preventing various medical dysfunctions and diseases arising from reactive oxygen species, in particular stroke, Parkinson's disease, Alzheimer's disease; lipid peroxidation inhibition activity
11/26/2003EP1017700B1 Macrocyclic porphyrazine-type compounds, metal derivatives thereof and process for their preparation
11/04/2003US6642206 Monocyclic L-nucleosides, analogs and uses thereof
10/2003
10/16/2003US20030195224 An immunomodulators, antitumor agents and induce cytokine biosynthesis, treating viral diseases
1 2 3 4 5